The safety of maternal immunization

References

• Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine 1998; 16(14-15):1456-63.; PMID:9711788; http://dx.doi.org/10.1016/S0264-410X(98)00108-X
   PubMed Web of Science ®Google Scholar
• Healy CM, Baker CJ. Maternal immunization. Pediatr Infect Dis J 2007; 26(10):945-8.; PMID:17901801; http://dx.doi.org/10.1097/INF.0b013e318156c18c
   PubMed Web of Science ®Google Scholar
• Mak DB, Regan AK, Joyce S, Gibbs R, Effler PV. Antenatal care provider's advice is they key determinant of influenza vaccination uptake in pregnant women. Aust N Z J Obstet Gynaecol 2015; 55(2):131-7.; PMID:25557858; http://dx.doi.org/10.1111/ajo.12292
   PubMed Web of Science ®Google Scholar
• Yuen CY, Tarrant M. Determinants of uptake of influenza vaccination among pregnant women - a systematic review. Vaccine 2014; 32(36):4602-13.; PMID:24996123; http://dx.doi.org/10.1016/j.vaccine.2014.06.067
   PubMed Web of Science ®Google Scholar
• Khromava A, Cohen CJ, Mazur M, Kanesa-thasan N, Crucitti A, Seifert H. Manufacturers' postmarketing safety surveillance of influenza vaccine exposure in pregnancy. Am J Obstet Gynecol 2012; 207(Supplement):S52-6.; PMID:22920060; http://dx.doi.org/10.1016/j.ajog.2012.06.074
   PubMedGoogle Scholar
• Shields KE, Galil K, Seward J, Sharrar RG, Cordero JF, Slater E. Varicella vaccine exposure during pregnancy: dta from the first 5 years of the pregnancy registry. Obstet Gynecol 2001; 98(1):14-9.; PMID:11430950
   PubMed Web of Science ®Google Scholar
• Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) – United States, 1991-2001. MMWR Surveill Summ 2003; 52(1):1-24.
   PubMedGoogle Scholar
• Regan AK, Blyth CC, Mak DB, Richmond PC, Effler PV. Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women. Aust N Z J Obstet Gynaecol 2014; 54(6):522-8.; PMID:25306915; http://dx.doi.org/10.1111/ajo.12266
   PubMed Web of Science ®Google Scholar
• Candela S, Pergolizzi S, Ragni P, Cavuto S, Nobilio L, Di Mario S, Dragosevic V, Groth N, Magrini N. An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one. Vaccine 2013; 31(10):1431-7.
   PubMed Web of Science ®Google Scholar
• Cassidy C, MacDonald NE, Steenbeek A, Ortiz JR, Zuber PL, Top KA. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants. Hum Vaccin Immunother 2016; 1-7; PMID:27159639 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, et al. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine 2014; 32:5390-8.; PMID:25108215; http://dx.doi.org/10.1016/j.vaccine.2014.07.073
   PubMed Web of Science ®Google Scholar
• Munoz FM. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol 2012; 207(3):S33-7.; PMID:22920057; http://dx.doi.org/10.1016/j.ajog.2012.06.072
   PubMedGoogle Scholar
• Bednarczyk RA, Adjaye-Gbewonyo D, Omer SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 2012; 207(3):S38-46.; PMID:22920058; http://dx.doi.org/10.1016/j.ajog.2012.07.002
   PubMedGoogle Scholar
• Carcione D, Blyth CC, Richmond PC, Mak DB, Effler PV. Safety surveillance of influenza vaccine in pregnant women. Aust N Z J Obstet Gynaecol 2013; 53(1):98-9.; PMID:23406000; http://dx.doi.org/10.1111/ajo.12034
   PubMed Web of Science ®Google Scholar
• Regan AK, Tracey L, Blyth CC, Mak DB, Richmond PC, Shellam G, Talbot C, Effler PV. A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy. Vaccine 2016; 34(20):2299-304; http://dx.doi.org/10.1016/j.vaccine.2016.03.084
   Google Scholar
• Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, Gelzen WP. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005; 192(4):1098-106.; PMID:15846187; http://dx.doi.org/10.1016/j.ajog.2004.12.019
   PubMed Web of Science ®Google Scholar
• Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004; 21(6):333-9.; PMID:15311370; http://dx.doi.org/10.1055/s-2004-831888
   PubMed Web of Science ®Google Scholar
• Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, Williams JL, Cragan J, Gee J, Thompson MG. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric evetns and findings from two recent cohort studies. Vaccine 2014; 32(26):3122-7.; PMID:24742490; http://dx.doi.org/10.1016/j.vaccine.2014.04.021
   PubMed Web of Science ®Google Scholar
• Nordin JD, Kharbanda EO, Benitez GV, Lipkind H, Vellozzi C, DeStefano F. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 2014; 164(5):1051-7.; PMID:24582484; http://dx.doi.org/10.1016/j.jpeds.2014.01.037
   PubMed Web of Science ®Google Scholar
• Omer SB, Goodman D, Steinhoff MC, Rochat R, Klugman KP, Stoll BJ, Ramakrishnan U. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011; 8(5):e1000441.; PMID:21655318; http://dx.doi.org/10.1371/journal.pmed.1000441
   PubMed Web of Science ®Google Scholar
• Ahrens KA, Louik C, Kerr S, Mitchell AA, Werler MM. Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth. Paediatri Perinat Epidemiol 2014; 28(6):498-509; http://dx.doi.org/10.1111/ppe.12152
   PubMed Web of Science ®Google Scholar
• Dodds L, Macdonald N, Scott J, Spencer A, Allen VM, McNeil S. The association between influenza vaccine in pregnancy and adverse neonatal outcomes. J Obstet Gynaecol Can 2012; 34(8):714-20.; PMID:22947404; http://dx.doi.org/10.1016/S1701-2163(16)35336-1
   PubMedGoogle Scholar
• Sheffield JS, Greer LG, Rogers VL, Roberts SW, Lytle H, McIntire DD, Wendel GD Jr. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol 2012; 120(3):532-7.; PMID:22914461; http://dx.doi.org/10.1097/AOG.0b013e318263a278
   PubMed Web of Science ®Google Scholar
• Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, DeStefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol 2013; 121(1):159-65.; PMID:23262941; http://dx.doi.org/10.1097/AOG.0b013e318279f56f
   PubMed Web of Science ®Google Scholar
• Regan AK, Moore HC, de Klerk N, Omer SB, Shellam G, Mak DB, Effler PV. Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study. Clin Infect Dis 2016; 62(10):1221-7.; PMID:27033634; http://dx.doi.org/10.1093/cid/ciw082
   PubMed Web of Science ®Google Scholar
• Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, Lee GM, Hambidge S, Shi W, Olsen A. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol 2013; 12(3):519-25.; PMID:NOT_FOUND; http://dx.doi.org/10.1097/AOG.0b013e3182831b83
   PubMedGoogle Scholar
• Mackenzie IS, MacDonald TM, Shakir S, Dryburgh, Mantay BJ, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol 2012; 73(5):801-11.; PMID:22082196; http://dx.doi.org/10.1111/j.1365-2125.2011.04142.x
   PubMed Web of Science ®Google Scholar
• Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 2011; 29(37):6358-65.; PMID:19439613
   PubMed Web of Science ®Google Scholar
• Omon E, Damase-Michel C, Hurault-Delarue C, Lacroix I, Montrastruc JL, Oustric S, Escourrou B. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine 2011; 29(52):9649-54.
   PubMed Web of Science ®Google Scholar
• Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, Barash F, Arana J, Brantley MD, Ding H, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011; 205(5):473.e471-479.
   Web of Science ®Google Scholar
• Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meiseter R, Schaefer C. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012; 30(30):4445-52.; PMID:19623686
   PubMed Web of Science ®Google Scholar
• Huang WT, Tang FW, Yang SE, Chih YC, Chuang JH. Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan. Vaccine 2014; 32(48):6463-8.
   PubMed Web of Science ®Google Scholar
• Fabiani M, Bella A, Rota MC, Clagnan E, Gallo T, D'Amato M, Pezzotti P, Ferrara L, Demicheli V, Martinelli D, et al. A/H1N1 pandemic influenza vaccination: a retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy. Vaccine 2015; 33(19):2240-7.; PMID:25820060; http://dx.doi.org/10.1016/j.vaccine.2015.03.041
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Young J, van Beek E, Franke H, Verstraeten T, Weil JG, Della Cioppa G. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012; 207(3):177.e1-8.; PMID:22939717; http://dx.doi.org/10.1016/j.ajog.2012.07.007
   PubMedGoogle Scholar
• Steinhoff MC, Omer SB, Roy E, El Arifeen S, Raqib R, Dodd C, Breiman RF, Zaman K. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012; 184(6):645-53.; PMID:22353593; http://dx.doi.org/10.1503/cmaj.110754
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Mirza SA, Vonglokham P, Khanthamaly V, Chitry B, Pholsena V, Chitranonh V, Omer SB, Moen A, Bresee JS, Corwin A, Xeuatvongsa A. The effect of influenza vaccination on birth outcomes in a cohort of pregnant women in Lao PDR, 2014-15. Clin Infect Dis 2016; 63(4):487-94; http://dx.doi.org/10.1093/cid/ciw290
   Web of Science ®Google Scholar
• Hutcheon JA, Fell DB, Jackson ML, Kramer MS, Ortiz JR, Savitz DA, Platt RW. Detectable risks in studies of the fetal benefits of maternal influenza vaccination. Am J Epidemiol 2016; 184(3):227-32; http://dx.doi.org/10.1093/aje/kww048
   Web of Science ®Google Scholar
• Savitz DA FD, Ortiz JR, Bhat N. Does influenza vaccinatin improve pregnancy outcome? Methodological issues and research needs. Vaccine 2015; 33:6430-5.; PMID:26319740; http://dx.doi.org/10.1016/j.vaccine.2015.08.041
   PubMed Web of Science ®Google Scholar
• Sukumaran LL, McCarthy N, Kharbanda EO, McNeil MM, Naleway AL, Klein NP, Jackson ML, Hambidge SJ, Lugg MM, Li R, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations. JAMA 2015; 314(15):1581-7.; PMID:26501534; http://dx.doi.org/10.1001/jama.2015.12790
   PubMed Web of Science ®Google Scholar
• Sukumaran LL, Mccarthy NO, Kharbanda ES, Weintraub ES, Vazquez-Benitez G, McNeil MM, Li R, Klein NP, Hambidge SJ, Naleway AL, et al. Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. Obstet Gynecol 2015; 126(5):1069-74.; PMID:26444109; http://dx.doi.org/10.1097/AOG.0000000000001066
   PubMed Web of Science ®Google Scholar
• Moro PL, Cragan J, Tepper N, Zheteyeva Y, Museru O, Lewis P, Broder K. Enhanced surveillance of tetanus toxoid, reduced diptheria toxoid, and acellular pertussis (Tdap) vaccines in prpegnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015. Vaccine 2016; 34(20):2349-53.; PMID:27013434
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway AL, Lee GM, Hambidge S, Jackson ML, Omer SB, et al. Maternal Tdap vaccination: coverage and acute safety outcomes in the Vaccine Safety Datalink, 2007-2013. Vaccine 2016; 34(7):968-73.; PMID:26765288
   PubMed Web of Science ®Google Scholar
• Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, et al. Adverse event reports after tetanus toxoid, reduced diptheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207(1):e1-7.; PMID:22727350; http://dx.doi.org/10.1016/j.ajog.2012.05.006
   PubMedGoogle Scholar
• Petousis-Harris H, Walls T, Watson D, Paynter J, Graham P, Turner N. Safety of Tdap vaccine in pregnant women: an observational study. BMJ Open 2016; 6(4):e010911; http://dx.doi.org/10.1136/bmjopen-2015-010911
   PubMed Web of Science ®Google Scholar
• Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014; 349:g4219.; PMID:25015137
   PubMed Web of Science ®Google Scholar
• Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant outcomes. J Pediatr. 2013; 163(5):1422-6.; PMID:23896191; http://dx.doi.org/10.1016/j.jpeds.2013.06.021
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway A, Omer SB, Hambidge SJ, Lee GM, Jackson ML, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA 2014; 312(18):1897-904.; PMID:25387187; http://dx.doi.org/10.1001/jama.2014.14825
   PubMed Web of Science ®Google Scholar
• Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunisation during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014; 311(17):1760-9.; PMID:24794369; http://dx.doi.org/10.1001/jama.2014.3633
   PubMed Web of Science ®Google Scholar
• Datwani H, Moro PL, Harrington T, Broder KR. Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System. Vaccine 2015; 33(27):3110-3.; PMID:25976546; http://dx.doi.org/10.1016/j.vaccine.2015.04.097
   PubMed Web of Science ®Google Scholar
• Regan AK, Tracey LE, Blyth CC, Richmond PC, Effler PV. A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy. Vaccine 2016; 34(20):2299-04.; PMID:27038132; http://dx.doi.org/10.1016/j.vaccine.2016.03.084
   PubMed Web of Science ®Google Scholar
• Sukumaran L, McNeil MM, Moro PL, Lewis PW, Winiecki SK, Shimabukuro TT. Adverse events following measles, mumps, and rubella vaccine in adults reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013. Clin Infect Dis 2015; 60(10):e58-65.; PMID:25637587
   PubMedGoogle Scholar
• Castillo-Solórzano C, Reef SE, Morice A, Vascones N, Chevez AE, Castalia-Soares R, Torres C, Vizzoti C, Ruiz Matus C. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. J Infect Dis 2011; 204(Suppl 1):S713-7.
   PubMed Web of Science ®Google Scholar
• Omer SB, Richards JL, Madhi SA, Tapia MD, Steinhoff MC, Aqil AR, Wairagkar N. Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: methods and expectations. Vaccine 2015; 33(32):3801; http://dx.doi.org/10.1016/j.vaccine.2015.05.077
   PubMed Web of Science ®Google Scholar
• Healy CM. Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol 2012; 55(2):474-86.; PMID:AMBIGUOUS
   PubMed Web of Science ®Google Scholar
• GAIA Consortium. Gaia at a glance. Available at: http://gaia-consortium.net/. Accessed 19 July 2016.
   Google Scholar
• Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009; 374:2115-22.; PMID:19880172; http://dx.doi.org/10.1016/S0140-6736(09)61877-8
   PubMed Web of Science ®Google Scholar